Disease and Therapy Review: StrokeTimely Data Resources, Inc.December 26, 2010 11 Pages - SKU: TDR6057221 |
| The Stroke Disease and Therapy Review provides an overview of the condition, with incidence, prevalence, and mortality numbers for major countries worldwide, information on diagnosis, and an overview of treatment for different types of strokes. Dosing and treatment cost information is provided for various treatment types and for medication. General information on the stroke market, as well as sales of leading drugs and therapies are provided.
Please note, this file is delivered as a Word file. |
Additional Information
Disease and Therapy Reviews were developed to provide a basic understanding of the key facts about a disease and market in a quick, easy-to-read format. These reports are prepared by the senior market research team of Timely Data Resources. Each Disease and Therapy Review provides a concise analysis of the most important information about a particular disease, its treatment, and the market opportunities. Reports begin with an overview of the condition, and also contain tables that summarize the available worldwide incidence and prevalence data for the condition, a review of current diagnosis strategies and treatment options, general information about the market size, and information about important market trends. The data contained in these reports comes from key industry secondary data sources, such as the Timely Data Resources Incidence and Prevalence Database, and Lange's Current Medical Diagnosis and Treatment. This information is supplemented by reviews of analyst reports, company reports, and medical websites. Sources and references are provided.
Related Markets
CNS/Neurology Reports
- Traumatic Brain Injury Global Clinical Trials Review, H1, 2012
- Tension -Type Headache Global Clinical Trials Review, H1, 2012
- Cluster Headache Syndrome Global Clinical Trials Review, H1, 2012
- Cerebral Infarction (Brain Infarction) Global Clinical Trials Review, H1, 2012
- Brain Ischemia Global Clinical Trials Review, H1, 2012

